DCC Plc/ IE0002424939 /
2024-11-12 3:48:18 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
73.3600USD | - | 1,109 Turnover: 80,622.6400 |
-Bid Size: - | -Ask Size: - | 6.72 bill.USD | - | - |
GlobeNewswire
07-10
Metrc Extends Track-and-Trace Partnership Through New Contract with State of California
GlobeNewswire
03-07
USO brings Dallas Cowboys Cheerleaders on tour to U.S. service members and their families in Korea
GlobeNewswire
02-20
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busines...
GlobeNewswire
2023-11-06
Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-10-25
Digital Check Corp. Adds Error Detection and Image Cleanup to its SecureLink by Digital Check® Netwo...
GlobeNewswire
2023-10-19
Vislink Amplifies Its Presence in U.S. Broadcast and Video Markets Via Strategic Agreement with AV D...
GlobeNewswire
2023-09-13
The University of St. Augustine for Health Sciences Leads the Charge Toward Effective, Compassionate...
GlobeNewswire
2023-08-28
CPI Aero Receives Second Multi-Year Contract and Funded Order for F-16 Aircraft Structures
GlobeNewswire
2022-03-28
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in N...
GlobeNewswire
2022-03-08
New AMD Ryzen Threadripper PRO 5000 WX-Series Processors are the Ultimate Workstation Processors for...
GlobeNewswire
2022-03-01
Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Busines...
GlobeNewswire
2022-02-15
Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
GlobeNewswire
2021-11-08
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-08-09
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update